Upregulation of hsa-miR-31-3p induced by ultraviolet affects keratinocytes permeability barrier by targeting CLDN1.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 07 06 2020
accepted: 23 06 2020
pubmed: 11 9 2020
medline: 12 3 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Chronic actinic dermatitis (CAD) is a photoallergic skin disease with complicated pathogenesis. However, skin barrier dysfunction may be involved according to clinical manifestation. To investigate the mechanism of CAD barrier dysfunction, noninvasive detection of skin barrier and small RNA sequencing were carried out. Quantitative real-time PCR (qRT-PCR) was used to evaluate the expression levels of hsa-miR-31-3p and CLDN1. The correlation between hsa-miR-31-3p and CAD severity was explored. Further, dual-luciferase reporter assay was performed to identify the relationship between hsa-miR-31-3p and CLDN1. In addition, expression of hsa-miR-31-3p was detected after ultraviolet (UV) irradiation. Influences of hsa-miR-31-3p on primary human keratinocytes barrier were assessed by FITC-Dextran permeability assay. Moreover, western blot was used to detect the expression of claudin-1, filaggrin, loricrin and involucrin. Our results showed that transepidermal water loss (TEWL) significantly increased in CAD, while stratum corneum hydration (SCH) significantly decreased. The expression of hsa-miR-31-3p was up-regulated in CAD while CLDN1 was down-regulated. Hsa-miR-31-3p was correlated with TEWL, UV-MED (minimal erythema dose) and clinical severity scores of CAD (CSS-CAD). Dual-luciferase reporter assay confirmed that hsa-miR-31-3p targeted the 3'UTR region of CLDN1. Moreover, hsa-miR-31-3p was induced by UVB (0-30 mJ/cm

Identifiants

pubmed: 32907715
pii: S0006-291X(20)31331-0
doi: 10.1016/j.bbrc.2020.06.113
pii:
doi:

Substances chimiques

3' Untranslated Regions 0
CLDN1 protein, human 0
Claudin-1 0
FLG protein, human 0
Filaggrin Proteins 0
MIRN31 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

626-632

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Yunhua Tu (Y)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China; Department of Dermatology, The Second People's Hospital of Guiyang, Guizhou, 550000, China.

Wenjuan Wu (W)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.

Yanni Guo (Y)

Department of Dermatology, The Second Affiliated Hospital of Fujian Medical University, Fujian, 675000, China.

Fengyan Lu (F)

Department of Dermatology, The First People's Hospital of Qujing, Qujing, 655000, China.

Dan Xu (D)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.

Xing Li (X)

Department of Dermatology, People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, 675000, China.

Yueting Zhao (Y)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.

Li He (L)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China. Electronic address: drheli2662@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH